• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Metallo-Drugs: Development and Action of Anticancer Agents

Metallo-Drugs: Development and Action of Anticancer Agents

9783110469844
1,587.60 zł
1,508.22 zł Save 79.38 zł Tax included
Lowest price within 30 days before promotion: 1,508.22 zł
Quantity
Available in 7-14 days

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Volume 18, entitled Metallo-Drugs:: Development and Action of Anticancer Agents of the series Metal Ions in Life Sciences centers on biological, medicinal inorganic chemistry. The serendipitous discovery of the antitumor activity of cis-diamminodichloroplatinum(II) (cisplatin) by Barnett Rosenberg in the 1960s is a landmark in metallodrug-based chemotherapy. The success of cisplatin in the clinic, followed by oxaliplatin and carboplatin, along with their drawbacks relating mainly to resistance development and severe toxicity, initiated research on polynuclear platinum complexes and on Pt(IV) complexes as prodrugs. Furthermore, the indicated shortcomings led to the exploration of other transition and main group metal ions, among them Ru(II/III), Au(I/III), Ti(IV), V(IV/V), and Ga(III) including also the essential metal ions Fe(II/III), Cu(I/II), and Zn(II). Ionic as well as covalent and non-covalent interactions between structurally very different complexes and biomolecules like nucleic acids, proteins, and carbohydrates are studied and discussed with regard to their possible anticancer actions. Hence, MILS-18 summarizes the research at the forefront of medicinal inorganic chemistry, including studies on the next-generation, tailor-made anticancer drugs. All this and more is treated in an authoritative and timely manner in the 17 stimulating chapters of this book, written by 39 internationally recognized experts from 10 nations (from the US via Europe to China and Australia). The impact of this vibrant research area is manifested by more than 2700 references, nearly 150 illustrations (more than half in color) and several comprehensive tables. Metallo-Drugs:: Development and Action of Anticancer Agents is an essential resource for scientists working in the wide range from enzymology, material sciences, analytical, organic, and inorganic biochemistry all the way through to medicine including the clinic ... not forgetting that it also provides excellent information for teaching.

Product Details
De Gruyter
72143
9783110469844
9783110469844

Data sheet

Publication date
2018
Issue number
1
Cover
hard cover
Pages count
588
Dimensions (mm)
170.00 x 240.00
Weight (g)
1192
  • From the Content:

    1. Introduction to the Wider Field of Metallo-Drugs
    2. Cisplatin and Oxaliplatin: Our Current Understanding of Their Actions
    3. Polynuclear Platinum Drugs: Covalent and Non-covalent DNA-Binding Agents
    4. Different Drugs, Different Actions: The Actions and Consequences of Trans and Cationic Platinum Drugs
    5. Platinum(IV) Drugs
    6. The Ruthenium Drugs KP1019 and NAMI-A: Our Current Understanding of Their Actions
    7. Ruthenium Piano-Stool Organometallic Drugs
    8. The Gold Drugs
    9. Titanium Drugs
    10. Vanadium Drugs
    11. Non-covalent Metallo-Drugs: Targeting Junction Structures
    12. Metallo-Drugs that Target Proteins
    13. Non-canonical Nucleic Acid Targets: Metallo-Drugs that Act on Quadruplexes
    14. Targeting, Delivery and Nanoscience of Metallo-Drugs
    15. Metallo-Intercalators
Comments (0)